We are live on
!
Find out more
IMDZ
Immune Design Corp.
IMDZ
IMDZ
Delisted
IMDZ was delisted on the 1st of April, 2019.
Fund managers haven’t disclosed any holdings of IMDZ yet.
IMDZ Hedge Fund Activity: Q2 2019 in Review
0 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2019, worth a combined $0 — down 100% from $165M a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of IMDZ and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Peter Svennilson, exiting entirely with an estimated $38.9M sold.
- 0 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2019, down from 68 in Q1 2019.
- Funds reported $0 of Immune Design Corp. stock for Q2 2019, down 100% quarter-over-quarter.
- 0 funds opened new Immune Design Corp. positions in Q2 2019 and 66 closed out, a net change of -66 holders.
- The largest Immune Design Corp. seller in Q2 2019 was Peter Svennilson, an estimated $38.9M sold.
Based on aggregated 13F filings for Q2 2019.